Celebrating women leading the business of life science innovation in metro New York and beyond
  • Home
  • About
  • Resources
    • Investment Firms
    • Incubators / Accelerators
    • Women’s Network
  • Metro NYC Events
Menu
  • Home
  • About
  • Resources
    • Investment Firms
    • Incubators / Accelerators
    • Women’s Network
  • Metro NYC Events
  • Home
  • About
  • Resources
    • Investment Firms
    • Incubators / Accelerators
    • Women’s Network
  • Metro NYC Events
  • Home
  • About
  • Resources
    • Investment Firms
    • Incubators / Accelerators
    • Women’s Network
  • Metro NYC Events
Lisa Ricciardi
Lisa Ricciardi
Photo of Nina Tandon
Photo of Nina Tandon
Carolyn Magill
Carolyn Magill
Rachelle Jacques
Rachelle Jacques
Nicole Wagner
Nicole Wagner
Kyoko Crawford
Kyoko Crawford
3 Women-Led Biotech Companies Focusing on Epigenetic Therapy
3 Women-Led Biotech Companies Focusing On Epigenetic Therapy
Read More...
Cognition Therapeutics Advancing Pipeline for Lead Candidate in Treatment of Neurodegenerative Disorders
Cognition Therapeutics Advancing Pipeline for Lead Candidate in Treatment of Neurodegenerative Disorders
Read More...
EpiBone Breaking Boundaries, not Bones
EpiBone Breaking Boundaries, not Bones
Read More...
Aetion’s Real World Evidence Platform Collaborates with FDA to Create Breakthroughs in Evaluating Covid-19
Aetion’s Real World Evidence Platform Collaborates with FDA to Create Breakthroughs in Evaluating Covid-19
Read More...
Enzyvant’s Rethymic to be the First FDtreatment for Pediatirc Congenital Athymia
Enzyvant's, Rethymic, First FDA Approved treatment for Pediatric Congenital Athymia
Read More...
LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa
LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa
Read More...
SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis
SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis
Read More...
previous arrow
next arrow
3 Women-Led Biotech Companies Focusing on Epigenetic Therapy
3 Women-Led Biotech Companies Focusing on Epigenetic Therapy
Cognition Therapeutics Advancing Pipeline for Lead Candidate in Treatment of Neurodegenerative Disorders
Cognition Therapeutics Advancing Pipeline for Lead Candidate in Treatment of Neurodegenerative Disorders
EpiBone Breaking Boundaries, not Bones
EpiBone Breaking Boundaries, not Bones
Aetion’s Real World Evidence Platform Collaborates with FDA to Create Breakthroughs in Evaluating Covid-19
Aetion’s Real World Evidence Platform Collaborates with FDA to Create Breakthroughs in Evaluating Covid-19
Enzyvant’s Rethymic to be the First FDtreatment for Pediatirc Congenital Athymia
Enzyvant’s Rethymic to be the First FDtreatment for Pediatirc Congenital Athymia
LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa
LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa
SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis
SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis
Feature Stories

SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis

Biotech MetropolitanMarch 25, 2022

LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa

Cognition Therapeutics Advances Lead Candidate in Treatment of Neurodegenerative Disorders

3 Women-Led Biotech Companies Focusing on Epigenetic Therapy

Enzyvant’s, Rethymic, First FDA Approved treatment for Pediatric Congenital Athymia

EpiBone Breaking Boundaries, not Bones

Geo Politics

Feature Stories

SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis

By Biotech MetropolitanMarch 25, 20220

According to the American Academy of Dermatology Association, one in five Americans will develop skin…

LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa

February 5, 2022

Cognition Therapeutics Advances Lead Candidate in Treatment of Neurodegenerative Disorders

January 7, 2022

3 Women-Led Biotech Companies Focusing on Epigenetic Therapy

January 1, 2022

Enzyvant’s, Rethymic, First FDA Approved treatment for Pediatric Congenital Athymia

December 20, 2021

Lifestyle

More from Lifestyle
Feature Stories

SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis

By Biotech MetropolitanMarch 25, 20220
Feature Stories

LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa

By Radhika ShahFebruary 5, 20220

Cognition Therapeutics Advances Lead Candidate in Treatment of Neurodegenerative Disorders

January 7, 2022

3 Women-Led Biotech Companies Focusing on Epigenetic Therapy

January 1, 2022

Enzyvant’s, Rethymic, First FDA Approved treatment for Pediatric Congenital Athymia

December 20, 2021

EpiBone Breaking Boundaries, not Bones

November 24, 2021

Aetion’s Real World Evidence Platform Collaborates with FDA to Create Breakthroughs in Evaluating Covid-19

June 29, 2020

In silico: How Envisagenics is using AI to Discover Biomarkers and New Therapies for Lung Cancer and Genetic Disease

June 28, 2020
Demo

Media & Culture

View More

SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis

March 25, 2022

LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa

February 5, 2022

Cognition Therapeutics Advances Lead Candidate in Treatment of Neurodegenerative Disorders

January 7, 2022

3 Women-Led Biotech Companies Focusing on Epigenetic Therapy

January 1, 2022

Enzyvant’s, Rethymic, First FDA Approved treatment for Pediatric Congenital Athymia

December 20, 2021

EpiBone Breaking Boundaries, not Bones

November 24, 2021

TOP NEWS

SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis

March 25, 20220

LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa

February 5, 20220

Cognition Therapeutics Advances Lead Candidate in Treatment of Neurodegenerative Disorders

January 7, 20220

3 Women-Led Biotech Companies Focusing on Epigenetic Therapy

January 1, 20220

Finance

Feature Stories

SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis

By Biotech MetropolitanMarch 25, 20220

LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa

February 5, 2022

Cognition Therapeutics Advances Lead Candidate in Treatment of Neurodegenerative Disorders

January 7, 2022

3 Women-Led Biotech Companies Focusing on Epigenetic Therapy

January 1, 2022
Feature Stories

SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis

Feature Stories

LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa

Top Posts

Cognition Therapeutics Advances Lead Candidate in Treatment of Neurodegenerative Disorders

By Radhika ShahJanuary 7, 20220

3 Women-Led Biotech Companies Focusing on Epigenetic Therapy

By Radhika ShahJanuary 1, 20220

Enzyvant’s, Rethymic, First FDA Approved treatment for Pediatric Congenital Athymia

By Christaphine Bob-RayDecember 20, 20210
Feature Stories

SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis

March 25, 2022

LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa

February 5, 2022

Cognition Therapeutics Advances Lead Candidate in Treatment of Neurodegenerative Disorders

January 7, 2022

3 Women-Led Biotech Companies Focusing on Epigenetic Therapy

January 1, 2022

Enzyvant’s, Rethymic, First FDA Approved treatment for Pediatric Congenital Athymia

December 20, 2021

EpiBone Breaking Boundaries, not Bones

November 24, 2021

Health Sciences

View More
Feature Stories

SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis

By Biotech MetropolitanMarch 25, 20220

According to the American Academy of Dermatology Association, one in five Americans will develop skin…

Feature Stories

LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa

By Radhika ShahFebruary 5, 20220

LambdaVision is a biotech company, that is designing and developing a protein-based artificial retina. This retina will utilize a light-activated protein, bacteriorhodopsin to restore function sight to those who are blind due to retinal degenerative diseases, including age-related macular degeneration (AMD) and retinitis pigmentosa (RP).

Cognition Therapeutics Advances Lead Candidate in Treatment of Neurodegenerative Disorders

January 7, 2022

3 Women-Led Biotech Companies Focusing on Epigenetic Therapy

January 1, 2022

Enzyvant’s, Rethymic, First FDA Approved treatment for Pediatric Congenital Athymia

December 20, 2021

EpiBone Breaking Boundaries, not Bones

November 24, 2021

Fitness

Feature Stories

SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis

Feature Stories

LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa

Feature Stories

Cognition Therapeutics Advances Lead Candidate in Treatment of Neurodegenerative Disorders

Home Decor

View More

SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis

March 25, 2022

LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa

February 5, 2022

Cognition Therapeutics Advances Lead Candidate in Treatment of Neurodegenerative Disorders

January 7, 2022

3 Women-Led Biotech Companies Focusing on Epigenetic Therapy

January 1, 2022

Enzyvant’s, Rethymic, First FDA Approved treatment for Pediatric Congenital Athymia

December 20, 2021

EpiBone Breaking Boundaries, not Bones

November 24, 2021

Luxury

View More
Feature Stories

SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis

By Biotech MetropolitanMarch 25, 20220

According to the American Academy of Dermatology Association, one in five Americans will develop skin…

LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa

February 5, 2022

Cognition Therapeutics Advances Lead Candidate in Treatment of Neurodegenerative Disorders

January 7, 2022

3 Women-Led Biotech Companies Focusing on Epigenetic Therapy

January 1, 2022

Enzyvant’s, Rethymic, First FDA Approved treatment for Pediatric Congenital Athymia

December 20, 2021

Science

SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis

LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa

Cognition Therapeutics Advances Lead Candidate in Treatment of Neurodegenerative Disorders

3 Women-Led Biotech Companies Focusing on Epigenetic Therapy

We Are Social
  • Facebook
  • Twitter
  • YouTube
  • TikTok
  • Telegram
  • WhatsApp

Sports

Feature Stories

EpiBone Breaking Boundaries, not Bones

By Radhika ShahNovember 24, 20210

Aetion’s Real World Evidence Platform Collaborates with FDA to Create Breakthroughs in Evaluating Covid-19

June 29, 2020

In silico: How Envisagenics is using AI to Discover Biomarkers and New Therapies for Lung Cancer and Genetic Disease

June 28, 2020

Women Advocating for Women – Kathryn Schubert takes on CEO of Society for Women’s Health Research

June 15, 2020

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

Entertainment

See More Posts
Feature Stories

SkinIO: Enabling Virtual Early Detection Powered by AI Image Skin Analysis

March 25, 2022
Feature Stories

LambdaVision Utilizing Bacteriorhodopsin to Bring Light To Sufferers of Age-Related Macular Degeneration and Retinitis Pigmentosa

February 5, 2022
Feature Stories

Cognition Therapeutics Advances Lead Candidate in Treatment of Neurodegenerative Disorders

January 7, 2022
Feature Stories

3 Women-Led Biotech Companies Focusing on Epigenetic Therapy

January 1, 2022
Feature Stories

Enzyvant’s, Rethymic, First FDA Approved treatment for Pediatric Congenital Athymia

December 20, 2021
Twitter Instagram

News

  • World
  • Business
  • Connections
  • Science

Company

  • Contact Info
  • Media Kits

Services

  • Newsletters

Subscribe to Updates

Get the latest news from Biotech Metropolitan Women.

Biotech Metropolitan Women ©2018-2022

  • Privacy Policy
  • Terms
  • Accessibility

Type above and press Enter to search. Press Esc to cancel.